Repligen beats top-line and bottom-line estimates; introduces FY26 outlook
Source: SeekingAlpha
2026-02-24 07:39:00 ET
More on Repligen
- Repligen Corporation (RGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Repligen Corporation (RGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript
- Repligen Q4 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Repligen
- Historical earnings data for Repligen
Read the full article on Seeking Alpha
For further details see:
Repligen beats top-line and bottom-line estimates; introduces FY26 outlook
Repligen Corporation
NASDAQ: RGEN
RGEN Trading
-2.48% G/L:
$121.33 Last:
161,575 Volume:
$120.66 Open:
RGEN Latest News
RGEN Stock Data
$8,061,398,164
55,615,260
0.31%
211
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
